Related Experiment Video
Updated: Apr 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Plasma exchanges and immunosuppression for anti-complement factor H associated hemolytic uremic syndrome
Priyanka Khandelwal1, Aditi Sinha, Pankaj Hari
1Division of Pediatric Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, AIIMS, New Delhi, India. Correspondence to: Dr Arvind Bagga, Division of Pediatric Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India. arvindbagga@hotmail.com.
Prompt treatment of atypical hemolytic uremic syndrome (aHUS) with anti-complement factor H antibodies can lead to remission of kidney function. Early intervention improves outcomes for patients with this rare kidney disease.
Area of Science:
- Nephrology
- Immunology
- Hematology
Background:
- Atypical hemolytic uremic syndrome (aHUS) linked to anti-complement factor H autoantibodies causes significant acute kidney injury.
- Many patients with aHUS require dialysis and face progressive renal failure.
Observation:
- Seven patients presented with gastrointestinal symptoms, acute kidney injury, and thrombotic microangiopathy.
- Elevated levels of anti-complement factor H antibodies were noted in these patients.
Findings:
- Rapid initiation of plasma exchange and immunosuppressive therapy was administered.
- Successful remission of hematological parameters and kidney function was achieved.
Implications:
- Timely and targeted management of antibody-associated aHUS is crucial for favorable patient outcomes.
- This approach offers a potential pathway to recovery for patients with severe kidney impairment due to aHUS.
More Related Videos
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Acute Kidney Injury V: Interprofessional Care
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant II: Surgical Procedure